PA
RGNX icon

Parallel Advisors’s Regenxbio RGNX Stock Holding History

Parallel Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803 Hold
67
– – ﹤0.01% 3725
2026
Q1 		$561 Hold
67
– – ﹤0.01% 3651
2025
Q4 		$965 Hold
67
– – ﹤0.01% 3305
2025
Q3 		$647 Hold
67
– – ﹤0.01% 3297
2025
Q2 		$550 Buy
67
+17
+34% +$142 ﹤0.01% 3297
2025
Q1 		$358 Hold
50
– – ﹤0.01% 3292
2024
Q4 		$387 Hold
50
– – ﹤0.01% 3275
2024
Q3 		$525 Hold
50
– – ﹤0.01% 3174
2024
Q2 		$585 Hold
50
– – ﹤0.01% 3071
2024
Q1 		$1.05K Hold
50
– – ﹤0.01% 2923
2023
Q4 		$898 Hold
50
– – ﹤0.01% 2958
2023
Q3 		$823 Hold
50
– – ﹤0.01% 3007
2023
Q2 		$1K Sell
50
-4
-7% -$77 ﹤0.01% 2932
2023
Q1 		$1.02K Hold
54
– – ﹤0.01% 2952
2022
Q4 		$1.23K Hold
54
– – ﹤0.01% 2851
2022
Q3 		$1K Sell
54
-7
-11% -$208 ﹤0.01% 3002
2022
Q2 		$2K Buy
61
+11
+22% +$275 ﹤0.01% 2623
2022
Q1 		$2K Sell
50
-18
-26% -$500 ﹤0.01% 2612
2021
Q4 		$2K Sell
68
-61
-47% -$2.08K ﹤0.01% 2746
2021
Q3 		$5K Buy
129
+63
+95% +$2.27K ﹤0.01% 2381
2021
Q2 		$3K Buy
66
+16
+32% +$572 ﹤0.01% 2486
2021
Q1 		$2K Hold
50
– – ﹤0.01% 2506
2020
Q4 		$2K Hold
50
– – ﹤0.01% 2341
2020
Q3 		$1K Hold
50
– – ﹤0.01% 2481
2020
Q2 		$1K Hold
50
– – ﹤0.01% 2359
2020
Q1 		$1K Buy
+50
New +$2.08K ﹤0.01% 2322

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Parallel Advisors's RGNX Position: Q2 2026 in Review

Parallel Advisors held its Regenxbio (RGNX) position steady in Q2 2026 at 67 shares worth $803. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

Parallel Advisors first reported a position in RGNX in Q1 2020 and has held it in 26 quarters since. The position peaked at $5K in Q3 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Parallel Advisors held 67 shares of Regenxbio worth $803 as of Q2 2026.
  • Parallel Advisors left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3725 holding.
  • Parallel Advisors first reported a position in Regenxbio in Q1 2020 and has held it in 26 quarters since.
  • Parallel Advisors's Regenxbio position peaked at $5K in Q3 2021.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.